<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35007">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01730820</url>
  </required_header>
  <id_info>
    <org_study_id>NEO CO</org_study_id>
    <secondary_id>A12-D20-VOL12</secondary_id>
    <nct_id>NCT01730820</nct_id>
  </id_info>
  <brief_title>Influence of Preload Dependence on the Effect of Phenylephrine on Cardiac Output</brief_title>
  <official_title>Influence of Preload Dependence on the Effect of Phenylephrine on Cardiac Output</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The perioperative hemodynamic management aims to ensure organ perfusion pressure and an
      oxygen arterial transport adapted to oxygen consumption. Phenylephrine is the Î±-adrenergic
      agonist widely used during anesthesia for arterial pressure control.

      Several questions on phenylephrine global and regional hemodynamics effects remain
      unresolved.

      The investigators assume that Phenylephrine may decrease cardiac output by increasing the
      afterload, while most likely could also make an increase or a stability of cardiac output by
      action on the venous return. The investigators propose an observational study assessing the
      influence of preload dependence, defined by the values of pulse pressure variation, on the
      effect of phenylephrine on cardiac output, measured beat by beat by esophageal Doppler.

      The aim of the investigators work is to improve the understanding of phenylephrine action, a
      daily use therapeutic action, to improve the patients care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>cardiac output</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparing  cardiac output values  before and after injection of a phenylephrine bolus, based on the existence of a preload dependency, defined by a measure of respiratory variation of pulse pressure greater than or equal to 13%.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypotension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        General anesthesia.Orotracheal intubation and mechanical ventilation Advanced Hemodynamic
        Monitoring intraoperative ( arterial pressure catheter, esophageal Doppler)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypotension (SBP &lt;90 mm Hg and / or MAP &lt;60 mm Hg)

          -  Injection of a bolus of phenylephrine at the discretion of the anesthesiologist
             physician in charge of the patient.

        Exclusion Criteria:

          -  Minor or major patient under guardianship

          -  Esophageal Diseases

          -  supra ventricular rhythm trouble

          -  Severe valvular

          -  Shunt intracardiac

          -  Vt &lt;7ml/kg theoretical weight

          -  heart rate / respiratory rate &lt;3.6

          -  Clinical hypepression of intra-abdominal

          -  Compliance &lt;30 mL/cmH2O

          -  pulmonary hypertension, Right ventricular failure

          -  Spontaneous Ventilation

          -  Thorax open

          -  VG severe dysfunction (LVEF &lt;40%)

          -  Prior Injection of ephedrine prior
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier REBET, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier REBET, M.D</last_name>
    <phone>+336111751</phone>
    <email>rebet-o@chu-caen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean Luc FELLAHI, M.D;Ph.D</last_name>
    <email>fellahi-jl@chu-caen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CAEN University Hospital</name>
      <address>
        <city>Caen</city>
        <state>Basse Normandie</state>
        <zip>1400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier REBET, M.D</last_name>
      <phone>+33611131751</phone>
      <email>rebet-o@chu-caen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean Luc FELLAHI, M.D;Ph.D</last_name>
      <email>fellahi-jl@chu-caen.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 20, 2012</lastchanged_date>
  <firstreceived_date>November 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
